IMS Health was acquired in 2010 by private equity firms TPG Capital, the Canada Pension Plan Investment Board and Leonard Green for $5.2 billion. Sales during the last fiscal year hit $2.5 billion, up 15 percent since 2009.
According to a NASDAQ report, IMS Health set a $100 million deal size as a placeholder, but the IPO is expected to easily raise $500 million and could hit the $1 billion mark.
More Articles on the Health IT Market:
North American Health IT Market to Hit $31.3B by 2017
Humana Launches Remote Monitoring Initiative
6 Trends in 2013’s Digital Health Funding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
